Today, I am discussing an emerging biotech company called MabVax Therapeutics (OTCQB:MBVX).
In order to gain more insight, I conducted an email interview with David Hansen, President and CEO of MabVax.
See interview at Seeking Alpha: http://seekingalpha.com/article/2688235-mabvax-is-under-the-radar-but-undervalued-ceo-david-hansen
No comments:
Post a Comment